NIH-funded research R01 grant

An intravaginal ring that prevents HIV and acts as a nonhormonal contraceptive.

Official title: Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception

Funded at Oak Crest Institute of Science · NIH-10805424 · Data updated 2026-11-12

This study is testing a new type of intravaginal ring that helps prevent both HIV and unwanted pregnancies, making it easier for women, especially in sub-Saharan Africa, to take care of their health with just one product.

More HIV Prevention research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOak Crest Institute of Science
NIH-funded
Lab location1 site (Monrovia, United States)
Project startMay 5, 2020
Project endFebruary 28, 2026
Funding year2024
Award (this year)$728,629
NIH project number5R01HD101344-05
Project IDNIH-10805424 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are young women in sub-Saharan Africa who are at risk of HIV infection and are seeking nonhormonal contraceptive options.

Less likely to help

Patients who are not at risk of HIV or who prefer hormonal contraceptive methods may not benefit from this research.

What this research studies

This research focuses on developing a next-generation intravaginal ring that serves dual purposes: preventing HIV infection and providing nonhormonal contraception. The approach involves creating a novel contraceptive agent using multivalent monoclonal antibodies that block sperm from reaching the egg, combined with antiretroviral agents that are effective in preventing HIV. This innovative device aims to increase uptake among women, particularly in sub-Saharan Africa, by addressing both their contraceptive needs and HIV prevention in a single product.

Why it matters

Potential benefit: If successful, this research could provide women with a safe and effective method for preventing both HIV and unintended pregnancies.

How similar studies have gone: While the concept of multipurpose prevention technologies is gaining interest, this specific approach using a dual-action intravaginal ring is relatively novel and has not been extensively tested in prior research.

Where this research is happening

  • Oak Crest Institute of Science
    Monrovia, United States
    Active

Researchers

  • Principal investigator: Baum, Marc Michael — Oak Crest Institute of Science
  • Study coordinator: Baum, Marc Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.